Immune markers associated with host susceptibility to infection with west nile virus

Viral Immunology

Volumn 27, Issue 2, 2014, Pages 39-47

  Qian, Feng ^a,f   Thakar, Juilee ^a,g   Yuan, Xiaoling ^a   Nolan, Melissa ^b   Murray, Kristy O ^b   Lee, William T ^c   Wong, Susan J ^c   Meng, Hailong ^a   Fikrig, Erol ^a,d   Kleinstein, Steven H ^a,e   Montgomery, Ruth R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c WADSWORTH CENTER   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e YALE UNIVERSITY   (United States)

^f FUDAN UNIVERSITY   (China)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NONSTRUCTURAL PROTEIN 1; TNFRSF12A PROTEIN; TNFRSF9 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE STATUS; INFECTION SENSITIVITY; MALE; MIDDLE AGED; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; VERY ELDERLY; WEST NILE FEVER; WEST NILE FLAVIVIRUS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; COHORT STUDIES; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TRANSCRIPTOME; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

EID: 84896763566     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0074     Document Type: Article

References (44)

1. Amanna IJ, Carlson NE, and Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Eng J Med 2007;357:1903-1915. (Pubitemid 350074686)
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, and Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Int Med 2006;144:705-714. (Pubitemid 46780630)
3. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008;198:984-993.
4. Colpitts TM, Conway MJ, Montgomery RR, and Fikrig E. West Nile virus: Biology, transmission and human infection. Clin Microbiol Rev 2012;25:635-648.
5. Davis CT, Ebel GD, Lanciotti RS, et al. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: Evidence for the emergence of a dominant genotype. Virology 2005;342:252-265. (Pubitemid 41566657)
6. Debiasi RL, and Tyler KL. West Nile virus meningoencephalitis. Nat Clin Prac 2006;2:264-275.
7. Dreux M, and Chisari FV. Viruses and the autophagy machinery. Cell Cycle 2010;9:1295-1307.
8. Du P, Kibbe WA, and Lin SM. Lumi: A pipeline for processing Illumina microarray. Bioinformatics 2008;24: 1547-1548. (Pubitemid 351911712)
9. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128:92-105. (Pubitemid 46073065)
10. Gadani SP, Cronk JC, Norris GT, and Kipnis J. IL-4 in the brain: A cytokine to remember. J Immunol 2012;189: 4213-4219.
11. Gattinoni L, Ji Y, Restifo NP. Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy. Clin Cancer Res 2010;6:4695-4701.
12. Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007;45:1039-1046. (Pubitemid 47580356)
13. Ishikawa H, and Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008;455:674-678.
14. Johnson WE, Li C, and Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007;8:118-127. (Pubitemid 44906106)
15. Klein SL, Jedlicka A, and Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010; 10:338-349.
16. Kong K-F, Delroux K, Wang X, et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 2008;82:7613-7623. (Pubitemid 352031228)
17. Krishnan MN, Ng A, Sukumaran B, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature 2008;455:242-245.
18. Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, and Tannenbaum SR. Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis 2012;6:e1887.
19. Langfelder P, and Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559.
20. Lanteri MC, O'Brien KM, Purtha WE, et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 2009;119: 3266-3277.
21. Lee HK, Lund JM, Ramanathan B, Mizushima N, and Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007;315:1398-1401. (Pubitemid 46399546)
22. Lim JK, and Murphy PM. Chemokine control of West Nile virus infection. Exper Cell Res 2011;317: 569-574.
23. Martin P, and Sanchez-Madrid F. CD69: An unexpected regulator of TH17 cell-driven inflammatory responses. Sci Signal 2011;4:pe14.
24. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, Beasley DW, Tesh RB, and Fisher-Hoch S. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010;201:2-4.
25. Murray KO, Baraniuk S, Resnick M, et al. Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004. Vector Borne Zoonotic Dis 2008;8:167-174. (Pubitemid 351630132)
26. Nolan MS, Schuermann J, and Murray KO. West Nile virus infection among Humas, Texas, USA, 2002-2011. Emerg Infect Dis 2013;19:137-139.
27. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, and Busch MP. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect 2013;141:591-595.
28. Prince HE, Lape-Nixon M, Yeh C, Tobler LH, and Busch MP. Persistence of antibodies to West Nile virus nonstructural protein 5. J Clin Virol 2008;43:102-106.
29. Qian F, Bolen CR, Wang X, et al. Impaired TLR3-mediated interferon responses from macrophages of patients chronically infected with hepatitis C virus. Clin Vaccine Immunol 2013;20:146-155.
30. Qian F, Chung L, Zheng W, et al. Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis. Viruses 2013;5:1664-1681.
31. Smyth GK.Limma: Linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, et al., (eds) Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer, New York, 2005; 397-420.
32. Sokol CL, and Medzhitov R. Role of basophils in the initiation of Th2 responses. Curr Op Immunol 2010; 22:73-77.
33. Song HY, Rothe M, and Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc. Nat Acad Sci USA 1996;93:6721-6725. (Pubitemid 26230376)
34. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci USA 2005;102:15545-15550. (Pubitemid 41528093)
35. Team RDC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2010.
36. Tobler LH, Cameron MJ, Lanteri MC, et al. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis 2008;198:979-983.
37. Verrier T, Solhonne B, Sallenave JM, and Garcia-Verdugo I. The WAP protein Trappin-2/Elafin: A handyman in the regulation of inflammatory and immune responses. Int J Biochem Cell Biol 2012;44:1377-1380.
38. Wang P, Arjona A, Zhang Y, Dai J, LeBlanc P, Doiron K, Sultana H, Saleh M, and Fikrig E. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol 2010;11:912-919.
39. Wang P, J Dai, F Bai, KF Kong, SJ Wong, RR Montgomery, JA Madri, E Fikrig 2008 Matrix metalloproteinase 9 facilitates West Nile Virus entry into the brain. J. Virol. 2008;82:8978-8985.
40. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, and Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Nat Acad Sci USA 2003;100:1896-1901 (Pubitemid 36254545)
41. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, and Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prevent 2008;17:3450-3456.
42. Wong SJ, Boyle RH, Demarest VL, et al. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Micro 2003;41:4217-4223. (Pubitemid 37099687)
43. Wong SJ, Demarest VL, Boyle RH, et al. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Micro 2004;42:65-72. (Pubitemid 38082700)
44. Yaqoob P, Newsholme EA, and Calder PC. Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. Cytokine 1999;11:600-605. (Pubitemid 29368978)